In addition, since PDE5 retained its significance when performing a multivariate analysis including PDE5 expression, ER, HER2, and lymph node status in the entire database, it is tempting to speculate that high PDE5 levels may independently predict poor outcome among patients with breast cancer. Here, ESR1 is linked to breast carcinoma.